Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
No abstract available
Article activity feed
-
SciScore for 10.1101/2020.02.18.20024364: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement Consent: Written informed consent was waived by the Ethics Commission of the designated hospital for emerging infectious diseases.
IRB: Written informed consent was waived by the Ethics Commission of the designated hospital for emerging infectious diseases.Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Antibodies Sentences Resources The exhaustion of T cells was detected using human CD4-percp (RPA-T4, Biolegend), CD8-APC (SK1, BD Biosciences), CD8-PE (SK1, Biolegend), PD-1-PE (EH12.2H7, Biolegend) and TIM-3-FITC (F38-2E2, Biolegend) antibodies. RPA-T4suggested: NoneCD8-APCsuggested…SciScore for 10.1101/2020.02.18.20024364: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement Consent: Written informed consent was waived by the Ethics Commission of the designated hospital for emerging infectious diseases.
IRB: Written informed consent was waived by the Ethics Commission of the designated hospital for emerging infectious diseases.Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Antibodies Sentences Resources The exhaustion of T cells was detected using human CD4-percp (RPA-T4, Biolegend), CD8-APC (SK1, BD Biosciences), CD8-PE (SK1, Biolegend), PD-1-PE (EH12.2H7, Biolegend) and TIM-3-FITC (F38-2E2, Biolegend) antibodies. RPA-T4suggested: NoneCD8-APCsuggested: NoneCD8-PEsuggested: NonePD-1-PEsuggested: NoneF38-2E2 , Biolegendsuggested: NoneSoftware and Algorithms Sentences Resources Statistical analysis: Statistical analyses were performed using GraphPad Prism version 8.0 (GraphPad Software, Inc. GraphPad Prismsuggested: (GraphPad Prism, RRID:SCR_002798)GraphPadsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
-